Arvinas shares gain as FDA approves breast cancer drug Veppanu
Go back to Arvinas shares gain as FDA approves breast cancer drug Veppanu| (NASDAQ: ARVN) | Delayed: 7.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.74 | 52 Week High | $ | |||
| Open | $7.74 | 52 Week Low | $ | |||
| Day High | $7.74 | P/E | N/A | |||
| Day Low | $7.74 | EPS | $ | |||
| Volume | 4,881 | |||||
